astuprotimut-R

	astuprotimut-R
Trade Name
Orphan Indication	MAGE-A3 positive stages IIb to IV malignant melanoma
USA Market Approval	USA
USA Designation Date	2009-05-29 00:00:00
Sponsor	GlaxoSmithKline Biologicals, S.A.;Rue de l'Institut 89;